North America benefits from advanced healthcare infrastructure, a strong presence of specialized cardiovascular centers, and widespread access to diagnostic and interventional technologies. The increasing number of coronary interventions and improvements in cardiac care facilities are expected to contribute to continued demand for bivalirudin and other anticoagulant therapies. Market Overview...